Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cancer Pathogenesis and Therapy, 2026
Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study

Ran L., Feng J., Chen J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Archives of Gerontology and Geriatrics, 2026
Hepatic dysfunction and long-term risk of neurodegenerative diseases: A UK Biobank-based analysis

Su W., Duan Q., He S. et al.

Olink Explore 3072/384NeurologyHepatologyPathophysiologyPlasma

Diabetic Medicine, 2026
A multi‐omics risk score enables early and personalized screening for type 2 diabetes: A population‐based cohort study

Bu F., Fang C., Zheng X. et al.

Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

eBioMedicine, 2026
Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap

Stinson S., Shadrin A., Rahman Z. et al.

Olink Explore 3072/384Metabolic DiseasesNeurologyPathophysiologyPlasma

Lipids in Health and Disease, 2026
Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study

Kim S., Jun H., Jo G. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Sato Y., Kodama T., Maesaka K. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of the American Society of Nephrology, 2026
RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis

Ye L., Jiang Z., Wu Y. et al.

Olink Explore 3072/384NephrologyPathophysiologyPlasma

ESC Heart Failure, 2026
Plasma protein profiles in different heart failure phenotypes

Lind L., Delgado-Velandia M.

Olink Explore 3072/384CVDPatient StratificationPlasma

Journal of Periodontal Research, 2026
Proteomic Characterization of Grade II Furcation Defects: A Discovery‐Phase Study

Chatzopoulos G., Sakellari D., Kaklamanos E. et al.

RevealOral DiseasesPatient StratificationGingival Crevicular Fluid

Hypertension, 2026
Integrative Proteomic Profiling of Blood Pressure and Hypertension

Aggarwal M., Joehanes R., Huan T. et al.

Olink Explore 3072/384Olink Explore HTCVDPathophysiologyPlasma

Translational Psychiatry, 2026
Astrocyte-related proteins mediate the association of YWHAG with Alzheimer’s pathology and enhance its diagnostic value

Zhang Z., Huang P., Yang Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationSerum

Lipids in Health and Disease, 2026
Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans

Larsson A., Eriksson L., Eriksson M.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Journal of Investigative Dermatology, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls

Sacknovitz Y., Zhou M., Kent J. et al.

Olink Target 96OncologyPatient StratificationSerum

Clinical Rheumatology, 2026
Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma

Wang H., Yan H., Yang M. et al.

Olink Target 96OncologyImmunological & Inflammatory DiseasesPathophysiologyPlasma

Cardiovascular Research, 2026
miR-146a-5p mediates atherogenic signalling from immune to vascular cells

Climent M., Zani S., Salvarani N. et al.

Olink Target 96 MouseT48 MouseCVDPathophysiologyMouse Serum

HemaSphere, 2026
Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

Diorio C., Myers R., Li Y. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationSerum

Metabolism, 2026
When the proteome meets the metabolome observational and Mendelian randomization analyses

Zheng R., Delgado-Velandia M., Ärnlöv J. et al.

Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

CNS Neuroscience & Therapeutics, 2026
Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via CCR2 / NFκB ‐Mediated Blood–Brain Barrier Disruption

Huang R., Gao L., Dai Y. et al.

Olink Target 96Neurovascular DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

Open Forum Infectious Diseases, 2026
Proteomic Profile After Intervention With Eplerenone Among Persons With HIV

Murthy A., Kolossváry M., Walpert A. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Pulmonology, 2026
Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study

He L., Liu C., Zhao H. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

4239 publications